Literature DB >> 9636557

Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.

R Shapiro1, M L Jordan, V P Scantlebury, C Vivas, H A Gritsch, J McCauley, D McQuitty, P Randhawa, W Irish, J McMichael, T R Hakala, R L Simmons, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9636557      PMCID： PMC2977954          DOI： 10.1016/s0041-1345(98)00280-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

Review 1.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; A Jain
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

3.  Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; J J Fung; C Jensen; C Vivas; J McCauley; W D Irish; S Mitchell; A J Demetris
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

4.  Tacrolimus in renal transplantation.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; H A Gritsch; J McCauley; D Ellis; N Gilboa; S Lombardozzi-Lane; P Randhawa; A J Demetris; W Irish; T R Hakala; R L Simmons; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1996-08       Impact factor: 1.066

Review 5.  Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

Authors:  T E Starzl; A J Demetris; M Trucco; N Murase; C Ricordi; S Ildstad; H Ramos; S Todo; A Tzakis; J J Fung
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

6.  Tacrolimus in pediatric renal transplantation.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; H A Gritsch; D Ellis; N Gilboa; S Lombardozzi-Lane; W Irish; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

Review 7.  Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.

Authors:  T E Starzl; A J Demetris; N Murase; A W Thomson; M Trucco; C Ricordi
Journal:  Immunol Today       Date:  1993-06

8.  A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.

Authors:  R Shapiro; M Jordan; V Scantlebury; C Vivas; J Fung; J McCauley; A Tzakis; P Randhawa; A J Demetris; W Irish
Journal:  Clin Transplant       Date:  1994-12       Impact factor: 2.863

9.  A prospective randomized trial of FK506-based immunosuppression after renal transplantation.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; S Mitchell
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

10.  FK506 in pediatric kidney transplantation--primary and rescue experience.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; A G Tzakis; D Ellis; N Gilboa; L Hopp; J McCauley; W Irish
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714
View more
  8 in total

1.  Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.

Authors:  P Chakrabarti; H Y Wong; A Toyofuku; V P Scantlebury; M L Jordan; C Vivas; A B Jain; J McCauley; J Johnston; P S Randhawa; T R Hakala; R L Simmons; J J Fung; T E Starzl; R Shapiro
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

3.  Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.

Authors:  M L Jordan; P Chakrabarti; P Luke; R Shapiro; C A Vivas; V P Scantlebury; J J Fung; T E Starzl; R J Corry
Journal:  Transplantation       Date:  2000-01-27       Impact factor: 4.939

4.  Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.

Authors:  P Chakrabarti; H Y Wong; V P Scantlebury; M L Jordan; C Vivas; D Ellis; S Lombardozzi-Lane; T R Hakala; J J Fung; R L Simmons; T E Starzl; R Shapiro
Journal:  Transplantation       Date:  2000-09-15       Impact factor: 4.939

Review 5.  Corticosteroid avoidance in pediatric renal transplantation.

Authors:  Jayakumar R Vidhun; Minnie M Sarwal
Journal:  Pediatr Nephrol       Date:  2005-02-03       Impact factor: 3.714

Review 6.  Corticosteroid avoidance in pediatric renal transplantation: can it be achieved?

Authors:  Jayakumar R Vidhun; Minnie M Sarwal
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 7.  Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?

Authors:  Fu L Luan; Diane E Steffick; Akinlolu O Ojo
Journal:  Kidney Int       Date:  2009-07-22       Impact factor: 10.612

Review 8.  Calcineurin inhibitors in renal transplantation: what is the best option?

Authors:  Kazunari Tanabe
Journal:  Drugs       Date:  2003       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.